Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records

Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records

Abstract Background Hepatitis C virus (HCV) is common among individuals in opioid agonist therapy (OAT). HCV treatment has previously been unavailable for most HCV positive OAT patients in Finland. The removal of treatment restrictions and attempts to reach HCV elimination goals have increased the n...

Full description

Bibliographic Details
Main Authors: Margareeta Häkkinen, Jouni Tourunen, Tuuli Pitkänen, Kaarlo Simojoki, Sauli Vuoti
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Substance Abuse Treatment, Prevention, and Policy
Subjects:
Hepatitis C
People who inject drugs
Opioid agonist therapy
Linkage to care
Point of care diagnostics
Online Access:https://doi.org/10.1186/s13011-022-00473-3

Internet

https://doi.org/10.1186/s13011-022-00473-3

Similar Items